TUMOR THERAPY USING MONOCLONAL ANTIBODIES HAVING THE PROPERTY OF BINDING TO PANCREATIC CARCINOMA CELLS

摘要

The use of a monoclonal antibody, of one of its non-Fc fragments or another ligand, which have the properties of blocking the pinocytosis of colloidal gold, the production of superoxide anions or the release of enzymes, particularly of neutral proteases, very particularly collagenase or elastase, of growth factors, epidermal growth factor, platelet-derived growth factor, colony-stimulating factor, erythropoietin, fibroblast growth factor, tumour angiogenesis factor or transforming growth factor from pancreatic tumour cells, for the therapy of tumours is described.